An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Postmarket Drug Safety Information for Patients and Providers

Sildenafil (marketed as Viagra and Revatio) Information

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Related Information

FDA Drug Saftey Communication: FDA clarifies Warning about Pediatric Use of Revatio (sildenafil) for Pulmonary Arterial Hypertension
FDA Drug Safety Communication: FDA recommends against use of Revatio in children with pulmonary hypertension
Comunicado de la FDA sobre la seguridad de los medicamentos La FDA recomienda que no se use Revatio en niÃ±os con hipertensiÃ³n pulmonary

Regulatory History and Labeling from Drugs@FDA

Regulatory History of Sildenafil

Top